FDA Warning Letter — Grimann, S.A. De C.V.

Case 632272 — FEI 3006076347

The FDA took a Warning Letter action against Grimann, S.A. De C.V. on May 23, 2022 (Lerma, Mexico). The action was issued by CDER and concerns drugs products.

Action Details

Facility
Grimann, S.A. De C.V.
Date
May 23, 2022
Fiscal Year
2022
Product Type
Drugs
Center
CDER
Location
Lerma (Mexico)

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.